Table 1 |
|
| Clinical features of patients with non-muscle invasive bladder carcinoma along with pathological and immunohistochemical characteristics of the resected tumors | |
| Clinical, pathological and immunohistochemical features (N=127) | |
| Gender | Cases (%) |
| Male | 94 (74) |
| Female | 33 (26) |
| Age (years, median, range) | 73 (41–87) |
| Tumor size: | Cases (%) |
| > 3 cm | 59 (46) |
| ≤ 3 cm | 68 (54) |
| Pathology: | Cases (%) |
| PUNLMP† | 54 (47) |
| LGPUC‡ | 61 (53) |
| Disease stage | Cases (%) |
| Ta | 54 (46%) |
| T1 | 64 (54%) |
| Median follow-up (months) | 37 |
| COX-2 Allred score | Cases (%) |
| 0 | 29 (29) |
| 1 | 16 (16) |
| 2 | 54 (55) |
| TILs* | Cases (%) |
| No | 44 (41) |
| Yes | 64 (59) |
Note: †PUNLMP indicates papillary urothelial neoplasm of low malignant potential; ‡LGPUC, low-grade papillary urothelial carcinoma; *TILs, tumor-infiltrating lymphocytes.
Tadin et al. Diagnostic Pathology 2012 7:152 doi:10.1186/1746-1596-7-152
